Novavax.
company in Gaithersburg, Maryland
- Reports this week
- 0
- Active events
- 0
- Connections
- 63
What's happening
Earlier this month
-
Novavax and Sanofi announced a partnership to facilitate vaccine access.Well supported3 reports1 development inside
-
Novavax and Sanofi are conducting a Phase 3 vaccine study in Europe under a collaboration agreement.Some support1 report
-
Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.Some support10 reports
-
Genmab and Novavax, both healthcare companies, are being compared regarding their therapeutic development in Denmark.Some support1 report
One to three months ago
-
AstraZeneca and Novavax are pursuing technology transfer to enable local vaccine production.Some support1 report
-
On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.Some support1 report
Gone quiet
No new reports in 90+ days-
Novavax, Nvidia, Biogen, and Amgen are involved in developments regarding specialized infrastructure and their shared status as peers in the therapeutics segment.Some support2 reports
-
Taiwan is utilizing Moderna and Novavax doses for COVID-19 vaccination.Some support1 report
-
Novavax is involved in managing specific vaccine stock for high-risk groups under the oversight of a governmental public health body.Some support2 reports
-
Market performance comparison in the vaccine sector was noted, alongside an upcoming August 5th FDA decision on a flu candidate.Some support1 report
-
Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.Some support1 report
-
AI stocks benefit from Trump-era tariffs, while Novavax released data showing its flu vaccine outperformed FLUZONE-HD.Some support2 reports
-
Novavax and Canopy Growth are facing lagging stock performance while operating in Canada and Germany.Some support1 report
-
Novavax is a vaccine maker operating in the medical sector.Some support1 report
-
Novavax's stock performance on July 31, 2025, was noted against the backdrop of the broader market's losses, showing both lags and outperformance.Some support3 reports
-
FDA approved Novavax's Nuvaxovid BLA, leading to Sanofi receiving a milestone payment and taking over U.S. commercial leadership.Well supported9 reports1 development inside
-
Incepta Pharmaceuticals and Novavax were mentioned in a report on August 13, 2025, noting that industry performance influences stock trends.Some support1 report
-
Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.Some support1 report
-
FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.Well supported6 reports1 development inside
-
Novavax started using LinkedIn on September 3, 2025, for company information.Some support2 reports
-
Novavax received a milestone payment following regulatory approval in Japan.Some support1 report
-
Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.Some support4 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Novavax
Events traced to Novavax, step by step, newest first- Sanofi's revenue surge could support Novavax's market momentumSanofi's 68% revenue jump may boost Novavax's commercial momentum.Possible
- Sanofi's vaccine project may boost Novavax's commercial standingSanofi's major vaccine project could strengthen its capabilities, benefiting NovavaxPossible
- Moderna and Merck's vaccine success could pressure Novavax's market shareModerna and Merck's successful cancer vaccine may increase competition for Novavax.Possible
- Moderna's successful mRNA cancer trial may increase pressure on NovavaxModerna's successful mRNA cancer trial may increase pressure on NovavaxPossible
Around Novavax this week
News at the entities that move Novavax most-
FDA StructuralFDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.Moves Novavax
-
Food and Drug Administration StructuralThe Food and Drug Administration approved Bayer's new blood thinner on November 9th.Moves Novavax
-
Jefferies Financial Group Mentioned togetherGap Inc. filed with the SEC regarding institutional investment activity, and Jefferies downgraded its stock rating and target price.Moves Novavax
-
MarketBeat Mentioned togetherMarketBeat provided analyst recommendations comparing materials companies Barrick Mining and Salzgitter.Moves Novavax
-
Sanofi StructuralSanofi advances Kymera's degrader candidate.Moves Novavax
-
Sanofi OperationalAgomAb completed its IPO on Nasdaq, while Sanofi joined a Series D funding round.Moves Novavax
Connections
The 22 strongest of 63, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sanofi Structural
Novavax licensed its vaccine technology to Sanofi, which subsequently took over global commercialization efforts and milestone payments.
-
Moderna Operational
Novavax and Moderna are direct competitors in the vaccine market, vying for market share and influencing each other's stock performance.
-
FDA Structural
The FDA formally evaluates, regulates, and grants market approval for Novavax's vaccine products.
-
Pfizer Operational
Novavax and Pfizer are direct competitors offering alternative products in the market.
-
Takeda Structural
Takeda provides financial support to Novavax through royalty payments, boosting its market outlook.
-
Food and Drug Administration Structural
The FDA regulates Novavax, granting market access through approvals and imposing delays.
-
Sanofi Operational
An active commercial partnership exists where Sanofi's operations and revenue streams support Novavax's market momentum and product commercialization.
-
Biogen Operational
The evidence indicates that both companies are direct competitors operating as peers within the therapeutics segment.
Show all 22 connections
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides financial ratings and research notes on Novavax.
-
Beam Therapeutics Operational
Both companies are healthcare firms actively competing for investment capital.
-
Centers for Disease Control Operational
Novavax utilizes vaccine stock managed by the Centers for Disease Control for high-risk groups.
-
MarketBeat Mentioned together
MarketBeat aggregates and reports financial data, news, and stock ratings for Novavax.
-
LinkedIn Operational
Novavax actively uses LinkedIn as a platform to gather company and general information.
-
TD Cowen Mentioned together
A is a financial services firm whose business includes providing market analysis and ratings for companies like B.
-
Incepta Pharmaceuticals Mentioned together
Both Incepta Pharmaceuticals and Novavax are categorized within the medical sector.
-
Citigroup Transactional
Citigroup issued a sell rating on Novavax.
-
AstraZeneca Operational
Both Novavax and AstraZeneca are actively pursuing vaccine technology transfer.
-
Nasdaq Shared context
Novavax is listed and trades its shares on the Nasdaq stock exchange.
-
Nvidia Shared context
The two companies operate within the same high-tech ecosystem, where Nvidia's products require specialized infrastructure.
-
Gaithersburg Shared context
Novavax is based in Gaithersburg, Maryland.
-
Amgen Operational
Novavax and Amgen are identified as competitors operating within the therapeutics segment.
-
Ibb Shared context
No evidence was found linking Novavax and Ibb in the provided timeline.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
1 eventAugust 2026
2 events- On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.
- Novavax, Nvidia, Biogen, and Amgen are involved in developments regarding specialized infrastructure and their shared status as peers in the therapeutics segment.
Show 2 earlier months
July 2026
2 eventsJune 2026
15 events- Novavax and Sanofi announced a partnership to facilitate vaccine access.
- Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.
- Market performance comparison in the vaccine sector was noted, alongside an upcoming August 5th FDA decision on a flu candidate.
- Young's career timeline includes appointments at TechImmune, service on the Novavax board, and academic/professional ties to GlaxoSmithKline in NYC and Houston.
- AI stocks benefit from Trump-era tariffs, while Novavax released data showing its flu vaccine outperformed FLUZONE-HD.
- Novavax and Canopy Growth are facing lagging stock performance while operating in Canada and Germany.
- Novavax is a vaccine maker operating in the medical sector.
- Novavax's stock performance on July 31, 2025, was noted against the backdrop of the broader market's losses, showing both lags and outperformance.
- FDA approved Novavax's Nuvaxovid BLA, leading to Sanofi receiving a milestone payment and taking over U.S. commercial leadership.
- Incepta Pharmaceuticals and Novavax were mentioned in a report on August 13, 2025, noting that industry performance influences stock trends.
- Novavax faces an uncertain outlook regarding its vaccine programs, as reported by Bank of America.
- FDA approved updated COVID-19 vaccines on August 29, 2025, involving companies like Novavax, Moderna, and Pfizer.
- Novavax started using LinkedIn on September 3, 2025, for company information.
- Novavax received a milestone payment following regulatory approval in Japan.
- Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.